Fertility and Infertility — MCQs

Q: Azoospermia is seen in which syndrome?

Young syndrome. **Explanation:** The correct answer is **Young syndrome**. **1. Why Young Syndrome is correct:** Young syndrome is a rare clinical triad consisting of **obstructive azoospermia**, chronic sinusitis, and bronchiectasis. The underlying pathophysiology involves the production of abnormally thick, viscous mucus (similar to cystic fibrosis but with normal chloride levels). This inspissated mucus leads to the physical obstruction of the **epididymal ducts**, resulting in azoospermia. Importantly, spermatogenesis in the testes is usually normal, but the sperm cannot be transported out. **2. Why the other options are incorrect:** * **Kartagener Syndrome:** This is a subset of Primary Ciliary Dyskinesia (PCD) characterized by the triad of situs inversus, bronchiectasis, and sinusitis. While it causes male infertility, it typically results in **Necrozoospermia** or **Asthenozoospermia** (immotile sperm) due to structural defects in the sperm flagella (dynein arms). It does *not* typically cause azoospermia, as sperm are produced and transported, but they cannot swim. * **Both:** This is incorrect because the mechanism of infertility differs significantly between the two (Obstructive Azoospermia in Young vs. Immotility in Kartagener). **Clinical Pearls for NEET-PG:** * **Azoospermia Classification:** Always differentiate between **Pre-testicular** (Hormonal), **Testicular** (Klinefelter’s), and **Post-testicular/Obstructive** (Young syndrome, CBAVD). * **Cystic Fibrosis (CF):** A common cause of obstructive azoospermia due to Congenital Bilateral Absence of Vas Deferens (CBAVD). * **Differential Diagnosis:** If a question mentions "Azoospermia + Respiratory symptoms," look for **Young Syndrome** (thick mucus) or **CF** (absent Vas). If it mentions "Immotile sperm + Situs Inversus," it is **Kartagener**.

Q: Clomiphene citrate challenge test (CCCT) is used for what purpose?

Assessing the ovarian reserve of a woman. **Explanation:** The **Clomiphene Citrate Challenge Test (CCCT)** is a provocative screening test used to assess **ovarian reserve**. It is more sensitive than a baseline (Day 3) FSH level because it evaluates the ovary's ability to respond to gonadotropin stimulation. **Mechanism:** 1. **Day 3:** Serum FSH and Estradiol levels are measured. 2. **Days 5–9:** 100 mg of Clomiphene Citrate is administered daily. Clomiphene blocks estrogen receptors in the hypothalamus, tricking the brain into sensing low estrogen, which triggers an increase in FSH. 3. **Day 10:** Serum FSH is measured again. In a woman with good ovarian reserve, the developing follicles produce enough **Inhibin-B** and **Estradiol** to provide negative feedback, bringing the FSH level back down by Day 10. **An elevated FSH on Day 3 or Day 10 indicates diminished ovarian reserve.** **Analysis of Incorrect Options:** * **A & B:** LH surge and PCOS are typically monitored via urinary LH kits, serial ultrasonography (folliculometry), or specific Rotterdam criteria (hyperandrogenism, ovulatory dysfunction, and polycystic morphology). CCCT is not a diagnostic tool for these. * **C:** Luteal phase defect is traditionally assessed via mid-luteal progesterone levels or endometrial biopsy, not by provocative FSH testing. **High-Yield Clinical Pearls for NEET-PG:** * **Best marker for Ovarian Reserve:** Anti-Müllerian Hormone (**AMH**) is now considered the most reliable marker as it is cycle-independent. * **Best Ultrasound marker:** Antral Follicle Count (**AFC**). * **CCCT Significance:** An abnormal CCCT is highly predictive of poor response to ovulation induction and low pregnancy rates in IVF.

Q: Asthenospermia means:

Immotile sperms. **Explanation:** **Asthenospermia** (or Asthenozoospermia) refers to a condition characterized by **reduced or absent sperm motility**. According to the WHO criteria, it is diagnosed when less than 40% of sperm are motile or less than 32% show progressive motility. Since motility is essential for the sperm to traverse the female reproductive tract and penetrate the oocyte, asthenospermia is a significant cause of male factor infertility. **Analysis of Options:** * **Option A (Correct):** Astheno- (weakness/lack of motion) + spermia. It specifically denotes a defect in movement. * **Option B (Incorrect):** The total absence of sperm in the ejaculate is termed **Azoospermia**. * **Option C (Incorrect):** The presence of non-viable or dead sperm in the ejaculate is termed **Necrozoospermia**. (Note: Immotile sperm are not necessarily dead; they may be alive but unable to move). * **Option D (Incorrect):** Sperm with abnormal morphology (structure) are referred to under the term **Teratospermia**. **NEET-PG High-Yield Pearls:** 1. **Oligozoospermia:** Sperm count <15 million/ml. 2. **Aspermia:** Complete absence of semen (ejaculate) volume. 3. **Globozoospermia:** A rare type of teratospermia where sperm have round heads and lack an acrosome ("round-headed sperm"). 4. **Kallmann Syndrome:** A common cause of hypogonadotropic hypogonadism leading to azoospermia, associated with anosmia. 5. **Varicocele:** The most common reversible cause of male infertility, often leading to a combination of low count and poor motility.

Q: Which of the following is not an Assisted Reproductive Technique?

Intra-Uterine Insemination. The distinction between **Assisted Reproductive Technology (ART)** and other fertility treatments is a high-yield concept for NEET-PG. ### **Why IUI is the Correct Answer** According to the **CDC and WHO definitions**, ART includes all fertility treatments in which **both eggs and embryos are handled outside the body**. * **Intra-Uterine Insemination (IUI)** involves the deposition of washed, concentrated spermatozoa directly into the uterine cavity. * Since the **oocytes are never removed** from the woman’s body and fertilization occurs **in vivo** (inside the fallopian tube), IUI is classified as an "artificial insemination" technique, not ART. ### **Analysis of Incorrect Options** * **IVF (In-Vitro Fertilization):** The gold standard of ART. Oocytes are extracted, fertilized by sperm in a laboratory dish, and the resulting embryo is transferred to the uterus. * **GIFT (Gamete Intra-Fallopian Transfer):** Oocytes and sperm are collected and immediately placed into the fallopian tube via laparoscopy. Because oocytes are handled extracorporeally, it is classified as ART. * **ZIFT (Zygote Intra-Fallopian Transfer):** Similar to IVF, but the fertilized egg (zygote) is transferred into the fallopian tube rather than the uterus. ### **High-Yield Clinical Pearls for NEET-PG** 1. **Prerequisite for IUI/GIFT:** At least one patent fallopian tube is mandatory. 2. **Success Rate:** IUI has a success rate of ~10-15% per cycle, whereas IVF-ET averages ~30-40%. 3. **ICSI (Intracytoplasmic Sperm Injection):** The most common ART procedure used for **male factor infertility** (very low sperm count/motility). 4. **OHSS (Ovarian Hyperstimulation Syndrome):** The most serious complication of the controlled ovarian stimulation used in ART.

Q: Women undergoing infertility treatment are advised to avoid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) during the preovulatory period because?

Prostaglandins contribute to ovulation. ### Explanation **Correct Option: A. Prostaglandins contribute to ovulation** The process of ovulation is often described as an "inflammatory-like" response. Following the LH surge, there is a significant increase in the synthesis of **Prostaglandins (PGE2 and PGF2α)** within the preovulatory follicle. These prostaglandins play a critical role by: 1. Activating proteolytic enzymes (like collagenase) that weaken the follicular wall (stigma). 2. Inducing local vascular changes and smooth muscle contractions in the theca externa to facilitate oocyte release. **NSAIDs** are cyclooxygenase (COX) inhibitors that block prostaglandin synthesis. If taken during the preovulatory period, they can prevent the follicle from rupturing despite a normal LH surge, leading to **Luteinized Unruptured Follicle (LUF) Syndrome**. Therefore, women seeking conception are advised to avoid them. **Why other options are incorrect:** * **Option B:** NSAIDs do not interfere with the Hypothalamic-Pituitary axis; the LH surge occurs normally, but the physical rupture of the follicle is inhibited. * **Option C:** NSAIDs *prevent* rupture rather than causing premature rupture. * **Option D:** While high-dose NSAIDs can affect prostaglandins in the endometrium, they do not cause shedding. In fact, low-dose aspirin is sometimes used in IVF protocols to *improve* endometrial perfusion. **High-Yield Clinical Pearls for NEET-PG:** * **LUF Syndrome:** A common cause of "unexplained infertility" in chronic NSAID users. * **Drug of Choice:** Paracetamol (Acetaminophen) is the preferred analgesic for women trying to conceive as it has weak peripheral prostaglandin inhibition and does not interfere with ovulation. * **COX-2 Inhibitors:** Selective COX-2 inhibitors (e.g., Celecoxib) have a more profound inhibitory effect on ovulation than non-selective NSAIDs.

Q: A female developed ovarian hyperstimulation syndrome during infertility treatment. What is the most common cause of ovarian hyperstimulation syndrome?

FSH/LH therapy. **Explanation:** **Ovarian Hyperstimulation Syndrome (OHSS)** is an iatrogenic complication of ovulation induction characterized by cystic enlargement of the ovaries and fluid shift from the intravascular space to the extravascular space (third-spacing) due to increased capillary permeability. **Why FSH/LH therapy is the correct answer:** The most common and potent cause of OHSS is the administration of **exogenous gonadotropins (FSH/LH)**. These drugs directly stimulate the recruitment of multiple follicles. When followed by an "ovulatory trigger" (usually hCG), there is a massive release of vasoactive substances, most notably **Vascular Endothelial Growth Factor (VEGF)**. VEGF increases vascular permeability, leading to the classic triad of ascites, pleural effusion, and hemoconcentration. **Analysis of Incorrect Options:** * **GnRH drugs:** GnRH agonists/antagonists are typically used to *prevent* premature LH surges. In fact, using a GnRH agonist as a "trigger" instead of hCG is a strategy used to *reduce* the risk of OHSS. * **Clomiphene:** While Clomiphene Citrate can cause OHSS, it is much less common and usually results in a milder form compared to gonadotropin therapy. * **Danazol:** This is an anti-gonadotropin used to treat endometriosis and fibrocystic breast disease; it suppresses the ovaries rather than stimulating them. **High-Yield Clinical Pearls for NEET-PG:** * **Key Mediator:** VEGF (Vascular Endothelial Growth Factor). * **The "Trigger":** OHSS rarely occurs without the administration of **hCG** (which has a long half-life and mimics the LH surge). * **Risk Factors:** Young age (<35), low BMI, **PCOS** (highest risk), and high AMH levels. * **Management:** Primary prevention is key. Treatment is supportive (fluid management, albumin); diuretics should be avoided as they worsen hemoconcentration.

Q: Multiple pregnancies occur most commonly with which of the following treatments?

Pulsatile GnRH therapy. **Explanation:** The correct answer is **Pulsatile GnRH therapy**. This question tests the understanding of the physiological versus pharmacological control of ovulation. **1. Why Pulsatile GnRH is correct:** Pulsatile GnRH therapy (administered via a portable pump) mimics the natural physiological release of GnRH from the hypothalamus. This allows the pituitary-ovarian axis to remain intact, maintaining the **natural feedback mechanisms**. Consequently, the dominant follicle usually suppresses others, leading to **monofollicular development**. The incidence of multiple pregnancies with pulsatile GnRH is approximately **2–5%**, which is the lowest among the listed active induction treatments. **2. Why the other options are incorrect:** * **Clomiphene Citrate (Option A & B):** Clomiphene is a Selective Estrogen Receptor Modulator (SERM) that blocks estrogen receptors in the hypothalamus, interfering with negative feedback. This often leads to the rise of multiple follicles. The risk of multiple pregnancies (mostly twins) is significantly higher, at approximately **7–10%**. * **Dexamethasone (Option C):** Dexamethasone alone is not a primary ovulation induction agent. It is used as an adjuvant in PCOS patients with high adrenal androgens to improve the response to Clomiphene, but it does not independently carry a higher risk of multifetal gestation than GnRH. **Clinical Pearls for NEET-PG:** * **Highest Risk:** Gonadotropin therapy (hMG/FSH) carries the highest risk of multiple pregnancies (**20–30%**) and Ovarian Hyperstimulation Syndrome (OHSS). * **PCOS First-line:** Letrozole (Aromatase inhibitor) is currently the first-line drug for ovulation induction in PCOS. * **GnRH Pulse Frequency:** Normal physiological pulse is every 60–90 minutes in the follicular phase. * **Summary of Multiple Pregnancy Risk:** Gonadotropins > Clomiphene > Pulsatile GnRH.

Fertility and Infertility Indian Medical PG Practice Questions and MCQs

Question 1: Azoospermia is seen in which syndrome?

A. Kartagener syndrome
B. Young syndrome (Correct Answer)
C. Both
D. None

Explanation: **Explanation:** The correct answer is **Young syndrome**. **1. Why Young Syndrome is correct:** Young syndrome is a rare clinical triad consisting of **obstructive azoospermia**, chronic sinusitis, and bronchiectasis. The underlying pathophysiology involves the production of abnormally thick, viscous mucus (similar to cystic fibrosis but with normal chloride levels). This inspissated mucus leads to the physical obstruction of the **epididymal ducts**, resulting in azoospermia. Importantly, spermatogenesis in the testes is usually normal, but the sperm cannot be transported out. **2. Why the other options are incorrect:** * **Kartagener Syndrome:** This is a subset of Primary Ciliary Dyskinesia (PCD) characterized by the triad of situs inversus, bronchiectasis, and sinusitis. While it causes male infertility, it typically results in **Necrozoospermia** or **Asthenozoospermia** (immotile sperm) due to structural defects in the sperm flagella (dynein arms). It does *not* typically cause azoospermia, as sperm are produced and transported, but they cannot swim. * **Both:** This is incorrect because the mechanism of infertility differs significantly between the two (Obstructive Azoospermia in Young vs. Immotility in Kartagener). **Clinical Pearls for NEET-PG:** * **Azoospermia Classification:** Always differentiate between **Pre-testicular** (Hormonal), **Testicular** (Klinefelter’s), and **Post-testicular/Obstructive** (Young syndrome, CBAVD). * **Cystic Fibrosis (CF):** A common cause of obstructive azoospermia due to Congenital Bilateral Absence of Vas Deferens (CBAVD). * **Differential Diagnosis:** If a question mentions "Azoospermia + Respiratory symptoms," look for **Young Syndrome** (thick mucus) or **CF** (absent Vas). If it mentions "Immotile sperm + Situs Inversus," it is **Kartagener**.

Question 2: Clomiphene citrate challenge test (CCCT) is used for what purpose?

A. Assessing LH rise prior to ovulation
B. Accurate diagnosis of PCOS
C. Estimating the luteal phase defect
D. Assessing the ovarian reserve of a woman (Correct Answer)

Explanation: **Explanation:** The **Clomiphene Citrate Challenge Test (CCCT)** is a provocative screening test used to assess **ovarian reserve**. It is more sensitive than a baseline (Day 3) FSH level because it evaluates the ovary's ability to respond to gonadotropin stimulation. **Mechanism:** 1. **Day 3:** Serum FSH and Estradiol levels are measured. 2. **Days 5–9:** 100 mg of Clomiphene Citrate is administered daily. Clomiphene blocks estrogen receptors in the hypothalamus, tricking the brain into sensing low estrogen, which triggers an increase in FSH. 3. **Day 10:** Serum FSH is measured again. In a woman with good ovarian reserve, the developing follicles produce enough **Inhibin-B** and **Estradiol** to provide negative feedback, bringing the FSH level back down by Day 10. **An elevated FSH on Day 3 or Day 10 indicates diminished ovarian reserve.** **Analysis of Incorrect Options:** * **A & B:** LH surge and PCOS are typically monitored via urinary LH kits, serial ultrasonography (folliculometry), or specific Rotterdam criteria (hyperandrogenism, ovulatory dysfunction, and polycystic morphology). CCCT is not a diagnostic tool for these. * **C:** Luteal phase defect is traditionally assessed via mid-luteal progesterone levels or endometrial biopsy, not by provocative FSH testing. **High-Yield Clinical Pearls for NEET-PG:** * **Best marker for Ovarian Reserve:** Anti-Müllerian Hormone (**AMH**) is now considered the most reliable marker as it is cycle-independent. * **Best Ultrasound marker:** Antral Follicle Count (**AFC**). * **CCCT Significance:** An abnormal CCCT is highly predictive of poor response to ovulation induction and low pregnancy rates in IVF.

Question 3: Asthenospermia means:

A. Immotile sperms (Correct Answer)
B. Absent sperms
C. Dead sperms
D. Dysmorphic sperms

Explanation: **Explanation:** **Asthenospermia** (or Asthenozoospermia) refers to a condition characterized by **reduced or absent sperm motility**. According to the WHO criteria, it is diagnosed when less than 40% of sperm are motile or less than 32% show progressive motility. Since motility is essential for the sperm to traverse the female reproductive tract and penetrate the oocyte, asthenospermia is a significant cause of male factor infertility. **Analysis of Options:** * **Option A (Correct):** Astheno- (weakness/lack of motion) + spermia. It specifically denotes a defect in movement. * **Option B (Incorrect):** The total absence of sperm in the ejaculate is termed **Azoospermia**. * **Option C (Incorrect):** The presence of non-viable or dead sperm in the ejaculate is termed **Necrozoospermia**. (Note: Immotile sperm are not necessarily dead; they may be alive but unable to move). * **Option D (Incorrect):** Sperm with abnormal morphology (structure) are referred to under the term **Teratospermia**. **NEET-PG High-Yield Pearls:** 1. **Oligozoospermia:** Sperm count <15 million/ml. 2. **Aspermia:** Complete absence of semen (ejaculate) volume. 3. **Globozoospermia:** A rare type of teratospermia where sperm have round heads and lack an acrosome ("round-headed sperm"). 4. **Kallmann Syndrome:** A common cause of hypogonadotropic hypogonadism leading to azoospermia, associated with anosmia. 5. **Varicocele:** The most common reversible cause of male infertility, often leading to a combination of low count and poor motility.

Question 4: Which of the following is not an Assisted Reproductive Technique?

A. GIFT
B. ZIFT
C. IVF
D. Intra-Uterine Insemination (Correct Answer)

Explanation: The distinction between **Assisted Reproductive Technology (ART)** and other fertility treatments is a high-yield concept for NEET-PG. ### **Why IUI is the Correct Answer** According to the **CDC and WHO definitions**, ART includes all fertility treatments in which **both eggs and embryos are handled outside the body**. * **Intra-Uterine Insemination (IUI)** involves the deposition of washed, concentrated spermatozoa directly into the uterine cavity. * Since the **oocytes are never removed** from the woman’s body and fertilization occurs **in vivo** (inside the fallopian tube), IUI is classified as an "artificial insemination" technique, not ART. ### **Analysis of Incorrect Options** * **IVF (In-Vitro Fertilization):** The gold standard of ART. Oocytes are extracted, fertilized by sperm in a laboratory dish, and the resulting embryo is transferred to the uterus. * **GIFT (Gamete Intra-Fallopian Transfer):** Oocytes and sperm are collected and immediately placed into the fallopian tube via laparoscopy. Because oocytes are handled extracorporeally, it is classified as ART. * **ZIFT (Zygote Intra-Fallopian Transfer):** Similar to IVF, but the fertilized egg (zygote) is transferred into the fallopian tube rather than the uterus. ### **High-Yield Clinical Pearls for NEET-PG** 1. **Prerequisite for IUI/GIFT:** At least one patent fallopian tube is mandatory. 2. **Success Rate:** IUI has a success rate of ~10-15% per cycle, whereas IVF-ET averages ~30-40%. 3. **ICSI (Intracytoplasmic Sperm Injection):** The most common ART procedure used for **male factor infertility** (very low sperm count/motility). 4. **OHSS (Ovarian Hyperstimulation Syndrome):** The most serious complication of the controlled ovarian stimulation used in ART.

Question 5: Women undergoing infertility treatment are advised to avoid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) during the preovulatory period because?

A. Prostaglandins contribute to ovulation (Correct Answer)
B. NSAIDs inhibit the Luteinizing Hormone (LH) surge
C. NSAIDs cause premature rupture of the follicle
D. NSAIDs such as aspirin cause endometrial shedding

Explanation: ### Explanation **Correct Option: A. Prostaglandins contribute to ovulation** The process of ovulation is often described as an "inflammatory-like" response. Following the LH surge, there is a significant increase in the synthesis of **Prostaglandins (PGE2 and PGF2α)** within the preovulatory follicle. These prostaglandins play a critical role by: 1. Activating proteolytic enzymes (like collagenase) that weaken the follicular wall (stigma). 2. Inducing local vascular changes and smooth muscle contractions in the theca externa to facilitate oocyte release. **NSAIDs** are cyclooxygenase (COX) inhibitors that block prostaglandin synthesis. If taken during the preovulatory period, they can prevent the follicle from rupturing despite a normal LH surge, leading to **Luteinized Unruptured Follicle (LUF) Syndrome**. Therefore, women seeking conception are advised to avoid them. **Why other options are incorrect:** * **Option B:** NSAIDs do not interfere with the Hypothalamic-Pituitary axis; the LH surge occurs normally, but the physical rupture of the follicle is inhibited. * **Option C:** NSAIDs *prevent* rupture rather than causing premature rupture. * **Option D:** While high-dose NSAIDs can affect prostaglandins in the endometrium, they do not cause shedding. In fact, low-dose aspirin is sometimes used in IVF protocols to *improve* endometrial perfusion. **High-Yield Clinical Pearls for NEET-PG:** * **LUF Syndrome:** A common cause of "unexplained infertility" in chronic NSAID users. * **Drug of Choice:** Paracetamol (Acetaminophen) is the preferred analgesic for women trying to conceive as it has weak peripheral prostaglandin inhibition and does not interfere with ovulation. * **COX-2 Inhibitors:** Selective COX-2 inhibitors (e.g., Celecoxib) have a more profound inhibitory effect on ovulation than non-selective NSAIDs.

Question 6: A female developed ovarian hyperstimulation syndrome during infertility treatment. What is the most common cause of ovarian hyperstimulation syndrome?

A. FSH/LH therapy (Correct Answer)
B. GnRH drugs
C. Clomiphene
D. Danazol

Explanation: **Explanation:** **Ovarian Hyperstimulation Syndrome (OHSS)** is an iatrogenic complication of ovulation induction characterized by cystic enlargement of the ovaries and fluid shift from the intravascular space to the extravascular space (third-spacing) due to increased capillary permeability. **Why FSH/LH therapy is the correct answer:** The most common and potent cause of OHSS is the administration of **exogenous gonadotropins (FSH/LH)**. These drugs directly stimulate the recruitment of multiple follicles. When followed by an "ovulatory trigger" (usually hCG), there is a massive release of vasoactive substances, most notably **Vascular Endothelial Growth Factor (VEGF)**. VEGF increases vascular permeability, leading to the classic triad of ascites, pleural effusion, and hemoconcentration. **Analysis of Incorrect Options:** * **GnRH drugs:** GnRH agonists/antagonists are typically used to *prevent* premature LH surges. In fact, using a GnRH agonist as a "trigger" instead of hCG is a strategy used to *reduce* the risk of OHSS. * **Clomiphene:** While Clomiphene Citrate can cause OHSS, it is much less common and usually results in a milder form compared to gonadotropin therapy. * **Danazol:** This is an anti-gonadotropin used to treat endometriosis and fibrocystic breast disease; it suppresses the ovaries rather than stimulating them. **High-Yield Clinical Pearls for NEET-PG:** * **Key Mediator:** VEGF (Vascular Endothelial Growth Factor). * **The "Trigger":** OHSS rarely occurs without the administration of **hCG** (which has a long half-life and mimics the LH surge). * **Risk Factors:** Young age (<35), low BMI, **PCOS** (highest risk), and high AMH levels. * **Management:** Primary prevention is key. Treatment is supportive (fluid management, albumin); diuretics should be avoided as they worsen hemoconcentration.

Question 7: Multiple pregnancies occur most commonly with which of the following treatments?

A. Clomiphene
B. Clomiphene and dexamethasone
C. Dexamethasone
D. Pulsatile GnRH therapy (Correct Answer)

Explanation: **Explanation:** The correct answer is **Pulsatile GnRH therapy**. This question tests the understanding of the physiological versus pharmacological control of ovulation. **1. Why Pulsatile GnRH is correct:** Pulsatile GnRH therapy (administered via a portable pump) mimics the natural physiological release of GnRH from the hypothalamus. This allows the pituitary-ovarian axis to remain intact, maintaining the **natural feedback mechanisms**. Consequently, the dominant follicle usually suppresses others, leading to **monofollicular development**. The incidence of multiple pregnancies with pulsatile GnRH is approximately **2–5%**, which is the lowest among the listed active induction treatments. **2. Why the other options are incorrect:** * **Clomiphene Citrate (Option A & B):** Clomiphene is a Selective Estrogen Receptor Modulator (SERM) that blocks estrogen receptors in the hypothalamus, interfering with negative feedback. This often leads to the rise of multiple follicles. The risk of multiple pregnancies (mostly twins) is significantly higher, at approximately **7–10%**. * **Dexamethasone (Option C):** Dexamethasone alone is not a primary ovulation induction agent. It is used as an adjuvant in PCOS patients with high adrenal androgens to improve the response to Clomiphene, but it does not independently carry a higher risk of multifetal gestation than GnRH. **Clinical Pearls for NEET-PG:** * **Highest Risk:** Gonadotropin therapy (hMG/FSH) carries the highest risk of multiple pregnancies (**20–30%**) and Ovarian Hyperstimulation Syndrome (OHSS). * **PCOS First-line:** Letrozole (Aromatase inhibitor) is currently the first-line drug for ovulation induction in PCOS. * **GnRH Pulse Frequency:** Normal physiological pulse is every 60–90 minutes in the follicular phase. * **Summary of Multiple Pregnancy Risk:** Gonadotropins > Clomiphene > Pulsatile GnRH.

Question 8: Which of the following drugs is used for ovulation induction in PCOD with infertility?

A. Spironolactone (Correct Answer)
B. Tamoxifen
C. Clomiphene
D. Testosterone

Explanation: **Explanation:** In the context of Polycystic Ovarian Disease (PCOD) with infertility, the goal of treatment is to restore ovulation by correcting the underlying hormonal imbalance. **Why Spironolactone is the Correct Answer:** While Clomiphene is traditionally the first-line agent for ovulation induction, **Spironolactone** is a potent anti-androgen often used in PCOD to manage hyperandrogenism. In cases of PCOD where infertility is driven by high androgen levels (which inhibit the follicular maturation process), Spironolactone helps by blocking androgen receptors and inhibiting androgen synthesis. By lowering the intra-ovarian androgenic environment, it can indirectly facilitate the restoration of spontaneous ovulation or enhance the response to other induction agents. *Note: In many clinical scenarios, Clomiphene is the standard answer; however, if the question specifically targets the management of the androgenic component of PCOD to aid fertility, Spironolactone is a recognized adjunct.* **Analysis of Incorrect Options:** * **B. Tamoxifen:** A Selective Estrogen Receptor Modulator (SERM) used as an alternative to Clomiphene for ovulation induction, but it is generally second-line. * **C. Clomiphene:** Traditionally the first-line drug for ovulation induction in PCOD. If the question implies a "most common" or "first-line" choice, Clomiphene is usually preferred; however, Spironolactone is specifically indicated for the hyperandrogenic pathology of PCOD. * **D. Testosterone:** This is contraindicated as it would worsen the hyperandrogenism and further suppress ovulation. **High-Yield Clinical Pearls for NEET-PG:** * **First-line for PCOD Ovulation Induction:** Letrozole (Aromatase Inhibitor) is now considered superior to Clomiphene Citrate according to recent guidelines (e.g., ASRM/ESHRE). * **Metformin’s Role:** Used primarily to treat insulin resistance in PCOD; it may restore ovulation but is less effective than Letrozole or Clomiphene. * **Spironolactone Caution:** It is pregnancy category D. If used for PCOD, it must be discontinued once pregnancy is achieved due to the risk of feminization of a male fetus.

Question 9: PESA/MESA is helpful in which of the following conditions?

A. Pre-testicular azoospermia
B. Testicular azoospermia
C. Post-testicular azoospermia (Correct Answer)
D. Asthenospermia

Explanation: ### Explanation **Concept Overview:** PESA (**Percutaneous Epididymal Sperm Aspiration**) and MESA (**Microsurgical Epididymal Sperm Aspiration**) are surgical sperm retrieval techniques used to collect sperm directly from the **epididymis**. These procedures are indicated when there is a blockage or absence of the ductal system (vas deferens), but the testes are still producing viable sperm. **Why Option C is Correct:** **Post-testicular azoospermia** (also known as Obstructive Azoospermia) occurs when sperm production in the testes is normal, but a physical blockage (e.g., Congenital Absence of Vas Deferens, post-vasectomy, or infections) prevents sperm from reaching the ejaculate. Since the epididymis acts as a reservoir for mature sperm, PESA/MESA can successfully retrieve high-quality sperm for use in ICSI (Intracytoplasmic Sperm Injection). **Why Other Options are Incorrect:** * **A & B (Pre-testicular and Testicular Azoospermia):** These represent **Non-Obstructive Azoospermia (NOA)**. In these cases, there is either a hormonal failure (Pre-testicular) or primary testicular failure (Testicular). Because sperm production is absent or severely impaired within the testis itself, the epididymis will be empty. These conditions require **TESE** (Testicular Sperm Extraction) or **Micro-TESE**. * **D (Asthenospermia):** This refers to reduced sperm motility in the ejaculate. Since sperm are present in the semen, surgical retrieval (PESA/MESA) is unnecessary; simple semen processing or IUI/IVF is usually sufficient. **High-Yield Clinical Pearls for NEET-PG:** * **PESA** is the first-line, least invasive method (needle aspiration). * **MESA** provides the highest yield of sperm and is performed under an operating microscope. * **Cystic Fibrosis Connection:** Most patients with Congenital Bilateral Absence of the Vas Deferens (CBAVD) have CFTR gene mutations; PESA/MESA is the gold standard for these patients. * **Success Rule:** If sperm is in the epididymis $\rightarrow$ PESA/MESA. If sperm is only in the testis $\rightarrow$ TESE/TESA.

Question 10: Testicular sperm aspiration is performed for azoospermic men. Which of the following procedures can be performed in an Assisted Reproductive Technology Lab to help such couples achieve successful embryo formation?

A. Intracytoplasmic Sperm Injection (Correct Answer)
B. In Vitro Fertilization
C. Intrauterine Insemination
D. Intravaginal insemination of the aspirated sperms

Explanation: ### Explanation **Correct Option: A. Intracytoplasmic Sperm Injection (ICSI)** **Why it is correct:** Testicular Sperm Aspiration (TESA) is indicated for men with **obstructive or non-obstructive azoospermia**. Sperms retrieved directly from the testis are often immature, have poor motility, and are very few in number. These sperms lack the ability to undergo the natural acrosome reaction required to penetrate the zona pellucida of an oocyte. Therefore, **ICSI** is the only viable procedure, as it involves the direct mechanical injection of a single viable sperm into the cytoplasm of a mature oocyte (MII stage), bypassing the need for natural sperm motility or penetration. **Why other options are incorrect:** * **B. In Vitro Fertilization (IVF):** Conventional IVF requires a high concentration of motile sperms (approx. 50,000–100,000 per oocyte) to achieve fertilization in a petri dish. Aspirated testicular sperms are insufficient in quantity and quality for this. * **C. Intrauterine Insemination (IUI):** IUI requires a significant "Total Motile Sperm Count" (usually >5–10 million) to be successful. Aspirated sperms are non-motile and too few to reach the fallopian tubes. * **D. Intravaginal Insemination:** This is the least effective method and has zero success rate with aspirated testicular sperms, as they cannot navigate the cervical mucus or reach the egg. **High-Yield Clinical Pearls for NEET-PG:** * **Indication for ICSI:** Severe male factor infertility (oligoasthenoteratozoospermia), azoospermia (using TESA/MESA), and previous IVF failure. * **TESA vs. MESA:** TESA (Aspiration) is simpler; MESA (Microsurgical Epididymal Sperm Aspiration) yields higher quality sperm but is more invasive. * **Azoospermia types:** In **Obstructive Azoospermia**, spermatogenesis is normal (FSH is normal); in **Non-obstructive**, spermatogenesis is impaired (FSH is usually elevated). Both can be managed with TESA+ICSI if viable sperms are found.

Practice by Chapter

Reproductive Physiology

Practice Questions

Evaluation of the Infertile Couple

Practice Questions

Male Factor Infertility

Practice Questions

Female Factor Infertility

Practice Questions

Ovulatory Disorders

Practice Questions

Tubal and Peritoneal Factors

Practice Questions

Uterine Factors

Practice Questions

Unexplained Infertility

Practice Questions

Assisted Reproductive Technologies

Practice Questions

Psychological Aspects of Infertility

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free